Associations of the BRAF (V600E) mutation and p53 protein expression with clinicopathological features of papillary thyroid carcinomas patients

Author：                

Publisher： Spandidos Publications

E-ISSN： 1792-1082|10|3|1882-1888

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.3, 2015-01, pp. : 1882-1888

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma

By He Guoping   Zhao Baojian   Zhang Xu   Gong Rixiang  

Oncology Letters, Vol. 7, Iss. 2, 2014-02 ,pp. : 439-443

Spandidos Publications

Access to resources Recommend Favorite

PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms

By                        

International Journal of Oncology, Vol. 44, Iss. 2, 2014-01 ,pp. : 548-556

Spandidos Publications

Access to resources Recommend Favorite

Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules

By              

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2633-2638

Spandidos Publications

Access to resources Recommend Favorite

Multicentric occurrence of multiple papillary thyroid carcinomas –HUMARA and BRAF mutation analysis

By  

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1272-1280

John Wiley & Sons Inc

Access to resources Recommend Favorite

B-Raf Mutations, Microsatellite Instability and p53 Protein Expression in Sporadic Basal Cell Carcinomas

By Stamatelli Angeliki  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 633-637

Springer Publishing Company

Access to resources Recommend Favorite